Synthetic biology and metabolic engineering of actinomycetes for natural product discovery
The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
Actinomycetes are one of the most valuable sources of natural products with industrial and medicinal importance. After more than half a century of exploitation, it has become increasingly challenging to find novel natural products with useful properties as the same known compounds are often repeatedly re-discovered when using traditional approaches. Modern genome mining approaches have led to the discovery of new biosynthetic gene clusters, thus indicating that actinomycetes still harbor a huge unexploited potential to produce novel natural products. In recent years, innovative synthetic biology and metabolic engineering tools have greatly accelerated the discovery of new natural products and the engineering of actinomycetes. In the first part of this review, we outline the successful application of metabolic engineering to optimize natural product production, focusing on the use of multi-omics data, genome-scale metabolic models, rational approaches to balance precursor pools, and the engineering of regulatory genes and regulatory elements. In the second part, we summarize the recent advances of synthetic biology for actinomycetal metabolic engineering including cluster assembly, cloning and expression, CRISPR/Cas9 technologies, and chassis strain development for natural product overproduction and discovery. Finally, we describe new advances in reprogramming biosynthetic pathways through polyketide synthase and non-ribosomal peptide synthetase engineering. These new developments are expected to revitalize discovery and development of new natural products with medicinal and other industrial applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 1×
“In the simplified system of the native CRISPR, the crRNA and the tracrRNA are fused into a single synthetic guide RNA (sgRNA) (Mali et al., 2013).”
BackgroundCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 20×
“system for defense against exogenous DNA or RNA (Barrangou et al., 2007).”
BackgroundInfluentialPractical streptomyces genetics
Kieser, T. (2000) · Medical Entomology and Zoology · Cited by 3,923
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Natural products (NP) are bioactive molecules that are used for many different purposes such as herbicides, chemotherapeutics, immunosuppressants, and antibiotics (Berdy, 2005; Berdy, 2012; Hwang et al., 2014).”
BackgroundCrystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · cited 1×
“Once the complex binds this specific target sequence, the Cas9 nuclease activity is triggered (Nishimasu et al., 2014).”
BackgroundDiversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423
A new logic for DNA engineering using recombination in Escherichia coli
Zhang, Y., Buchholz, F., Muyrers, J. P. P., & Stewart, A. F. (1998) · Nature Genetics · doi:10.1038/2417 · Cited by 1,222 · cited 6×
“One of the first applications of the RecET-mediated LLHR method was used to clone BGCs from Photorhabdus luminescens and express them in E. coli (Fu et al., 2012; Yin et al., 2015).”
BackgroundInfluentialThoughts and facts about antibiotics: Where we are now and where we are heading
Bérdy, J. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.27 · Cited by 1,165 · cited 2×
“Natural products (NP) are bioactive molecules that are used for many different purposes such as herbicides, chemotherapeutics, immunosuppressants, and antibiotics (Berdy, 2005; Berdy, 2012; Hwang et al., 2014).”
BackgroundantiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification
Blin, K., Wolf, T., Chevrette, M. G., Lu, X., Schwalen, C. J., Kautsar, S. A., Suarez Duran, H. G., de los Santos, E. L. C., Kim, H. U., Nave, M., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx319 · Cited by 1,158 · cited 2×
“…whole genome sequences can now be easily and cheaply obtained, genome mining for secondary metabolite biosynthetic gene clusters (BGCs) has become a routine method of NP discovery in actinomycetes (Ziemert et al., 2016) complementing the classical chemistry-driven screening (Blin et al., 2017).”
BackgroundMethodSelf-citationNonribosomal Peptide Synthesis—Principles and Prospects
Süssmuth, R. D., & Mainz, A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609079 · Cited by 958
Recombineering: a homologous recombination-based method of genetic engineering
Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., & Court, D. L. (2009) · Nature Protocols · doi:10.1038/nprot.2008.227 · Cited by 785 · cited 1×
“from the Rac prophage can be used for in vivo homologous recombination (Muyrers et al., 2000; Sharan et al., 2009).”
BackgroundThe world of subinhibitory antibiotic concentrations
Davies, J., Spiegelman, G. B., & Yim, G. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.006 · Cited by 750 · cited 1×
“In fact, the exposure to sub-inhibitory concentrations of antibiotics induces changes in the transcriptome profile in many different bacterial species, inducing metabolite and pigment production, differentiation, or motility (Davies, 2006; Davies et al., 2006; Romero et al., 2011).”
BackgroundSystems metabolic engineering of microorganisms for natural and non-natural chemicals
Lee, J. W., Na, D., Park, J. M., Lee, J., Choi, S., & Lee, S. Y. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.970 · Cited by 735 · cited 2×
“Systems metabolic engineering strategies (Lee et al., 2011; Lee et al., 2012; Lee and Kim, 2015) advancing rapidly will help establish even more efficient platforms for engineering actinomycetes for producing valuable natural and non-natural products (Kim et al.”
BackgroundSelf-citationMolecular Regulation of Antibiotic Biosynthesis in Streptomyces
Liu, G., Chater, K. F., Chandra, G., Niu, G., & Tan, H. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00054-12 · Cited by 714 · cited 18×
“Different studies demonstrated that exogenous feeding with precursors can indeed increase the production of polyketides, a large family of NPs built from acyl-CoA monomers (Chan et al., 2009; Mo et al., 2009).”
BackgroundInfluentialThe evolution of genome mining in microbes – a review
Ziemert, N., Alanjary, M., & Weber, T. (2016) · Natural Product Reports · doi:10.1039/c6np00025h · Cited by 688 · cited 1×
“become a routine method of NP discovery in actinomycetes (Ziemert et al., 2016) complementing the classical chemistry-driven screening (Blin et al.”
MethodSelf-citationA comprehensive metabolic map for production of bio-based chemicals
Lee, S. Y., Kim, H. U., Chae, T. U., Cho, J. S., Kim, J. W., Shin, J. H., Kim, D. I., Ko, Y.-S., Jang, W. D., & Jang, Y.-S. (2019) · Nature Catalysis · doi:10.1038/s41929-018-0212-4 · Cited by 607
Self-citationSystems strategies for developing industrial microbial strains
Lee, S. Y., & Kim, H. U. (2015) · Nature Biotechnology · doi:10.1038/nbt.3365 · Cited by 589 · cited 1×
“Systems metabolic engineering strategies (Lee et al., 2011; Lee et al., 2012; Lee and Kim, 2015) advancing rapidly will help establish even more efficient platforms for engineering actinomycetes for producing valuable natural and non-natural products (Kim et al.”
BackgroundSelf-citationCobb, R. E., Wang, Y., & Zhao, H. (2015) · ACS Synthetic Biology · doi:10.1021/sb500351f · Cited by 570 · cited 1×
“Streptomyces called pCRISPomyces was developed (Cobb et al., 2015) by Zhao and co-workers.”
Gomez‐Escribano, J. P., & Bibb, M. J. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00219.x · Cited by 534 · cited 2×
“Heterologous expression of BGCs has become an important approach for the discovery of NPs from silent gene clusters and for biosynthetic pathway refactoring (Gomez-Escribano and Bibb, 2011; Ren et al., 2017).”
BackgroundGenome-minimized Streptomyces host for the heterologous expression of secondary metabolism
Komatsu, M., Uchiyama, T., Ōmura, S., Cane, D. E., & Ikeda, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914833107 · Cited by 500
Classification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498
A roadmap for natural product discovery based on large-scale genomics and metabolomics
Doroghazi, J. R., Albright, J. C., Goering, A. W., Ju, K.-S., Haines, R. R., Tchalukov, K. A., Labeda, D. P., Kelleher, N. L., & Metcalf, W. W. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1659 · Cited by 476 · cited 1×
“about differentially abundant molecules such as oasamycin and desertomycin (Covington et al., 2017; Doroghazi et al., 2014).”
BackgroundYamanaka, K., Reynolds, K. A., Kersten, R. D., Ryan, K. S., Gonzalez, D. J., Nizet, V., Dorrestein, P. C., & Moore, B. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319584111 · Cited by 474 · cited 1×
“encoding the dichlorinated lipopeptide antibiotic taromycin A (Yamanaka et al., 2014); the type II PKS pathway for the biosynthesis of enterocin from Salinispora pacifica (Bonet et al.”
Actinomycetes: Still a source of novel antibiotics
Genilloud, O. (2017) · Natural Product Reports · doi:10.1039/c7np00026j · Cited by 465 · cited 1×
“Despite an increasing number of new NPs that have been discovered in past decades, the entire workflow from discovery to commercialization of NPs is challenging, time-consuming, and costly (Genilloud, 2017).”
BackgroundFu, J., Bian, X., Hu, S., Wang, H., Huang, F., Seibert, P. M., Plaza, A., Xia, L., Müller, R., Stewart, A. F., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2183 · Cited by 448
Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli
Pitera, D. J., Paddon, C. J., Newman, J. D., & Keasling, J. D. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2006.11.002 · Cited by 438 · cited 1×
“titer of the desired product are commonly observed (Bienick et al., 2014; Pitera et al., 2007).”
BackgroundCRISPR-Cas9 Based Engineering of Actinomycetal Genomes
Tong, Y., Charusanti, P., Zhang, L., Weber, T., & Lee, S. Y. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00038 · Cited by 432
Self-citationCloning and Heterologous Expression of the Epothilone Gene Cluster
Tang, L., Shah, S., Chung, L., Carney, J., Katz, L., Khosla, C., & Julien, B. (2000) · Science · doi:10.1126/science.287.5453.640 · Cited by 424
Antibiotics as Signal Molecules
Romero, D., Traxler, M. F., López, D., & Kolter, R. (2011) · Chemical Reviews · doi:10.1021/cr2000509 · Cited by 390
Wang, H., Marcišauskas, S., Sánchez, B. J., Domenzain, I., Hermansson, D., Agren, R., Nielsen, J., & Kerkhoven, E. J. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006541 · Cited by 381 · cited 2×
“In fact, due to the availability of a rich pool of precursors/ substrates and toolkits for genetic manipulation, along with relatively easy cultivation, Streptomyces strains are suitable hosts for the production of NP derived from both other actinomycetes and plants (Nepal and Wang, 2018).”
BackgroundMiao, V., Coëffet-LeGal, M.-F., Brian, P., Brost, R., Penn, J., Whiting, A., Martin, S., Ford, R., Parr, I., Bouchard, M., et al. (2005) · Microbiology · doi:10.1099/mic.0.27757-0 · Cited by 368
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349 · cited 1×
“In the last twenty years, only about 30 new drugs were approved, of which only five belong to novel structural classes (Butler et al., 2017).”
BackgroundBibb, M. J., Janssen, G. R., & Ward, J. M. (1985) · Gene · doi:10.1016/0378-1119(85)90220-3 · Cited by 346
Bibb, M. J., Janssen, G. R., & Ward, J. M. (1986) · Gene · doi:10.1016/0378-1119(86)90122-8 · Cited by 344
The structures of type I polyketide synthases
Keatinge-Clay, A. T. (2012) · Natural Product Reports · doi:10.1039/c2np20019h · Cited by 344 · cited 1×
“…whole genome sequencing, and the progress in understanding the structural blueprint of these megaenzymes and the interplay of the individual enzymatic domains (Keatinge-Clay, 2012; Kopp and Marahiel, 2007; Marahiel, 2016; Weissman, 2015) likely will provide novel approaches in the near future.”
BackgroundBiosynthesis of polyketide synthase extender units
Chan, Y. A., Podevels, A. M., Kevany, B. M., & Thomas, M. G. (2009) · Nat. Prod. Rep. · doi:10.1039/b801658p · Cited by 337 · cited 1×
“mily of NPs built from acyl-CoA monomers (Chan et al., 2009; Mo et al., 2009).”
BackgroundAn Engineered Strong Promoter for Streptomycetes
Wang, W., Li, X., Wang, J., Xiang, S., Feng, X., & Yang, K. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00985-13 · Cited by 310
CRISPR–Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters
Zhang, M. M., Wong, F. T., Wang, Y., Luo, S., Lim, Y. H., Heng, E., Yeo, W. L., Cobb, R. E., Enghiad, B., Ang, E. L., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2341 · Cited by 304 · cited 1×
“An extension of CRISPR/Cas9 technology was recently developed to perform strategic promoter knock-in for the activation of silent BGCs in native Streptomyces hosts (Zhang et al., 2017).”
BackgroundImproving production of bioactive secondary metabolites in actinomycetes by metabolic engineering
Olano, C., Lombó, F., Méndez, C., & Salas, J. A. (2008) · Metabolic Engineering · doi:10.1016/j.ymben.2008.07.001 · Cited by 299 · cited 1×
“and to redirect the flux towards the biosynthesis of the desired metabolite (Olano et al., 2008).”
BackgroundOne-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces
Huang, H., Zheng, G., Jiang, W., Hu, H., & Lu, Y. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv007 · Cited by 289
Transformation of plasmid DNA into Streptomyces at high frequency
BIBB, M. J., WARD, J. M., & HOPWOOD, D. A. (1978) · Nature · doi:10.1038/274398a0 · Cited by 283 · cited 1×
“Hopwood and colleagues established the DNA transformation protocol for Streptomyces in 1978 (Bibb et al., 1978), beginning”
BackgroundJiang, W., Zhao, X., Gabrieli, T., Lou, C., Ebenstein, Y., & Zhu, T. F. (2015) · Nature Communications · doi:10.1038/ncomms9101 · Cited by 267 · cited 3×
“Among the in vitro techniques available for BGC cloning a variation of the TAR system is the CATCH method (Jiang et al., 2015).”
MethodAre antibiotics naturally antibiotics?
Davies, J. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0112-5 · Cited by 259 · cited 1×
“In fact, the exposure to sub-inhibitory concentrations of antibiotics induces changes in the transcriptome profile in many different bacterial species, inducing metabolite and pigment production, differentiation, or motility (Davies, 2006; Davies et al., 2006; Romero et al., 2011).”
BackgroundRecent advances in systems metabolic engineering tools and strategies
Chae, T. U., Choi, S. Y., Kim, J. W., Ko, Y.-S., & Lee, S. Y. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.06.007 · Cited by 246
Self-citationShima, J., Hesketh, A., Okamoto, S., Kawamoto, S., & Ochi, K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.24.7276-7284.1996 · Cited by 243 · cited 1×
“This ribosome engineering approach led to the activation of silent BGCs in different Streptomyces and antibiotics overproduction (Shima et al., 1996; Wang et al., 2008).”
BackgroundKomatsu, M., Komatsu, K., Koiwai, H., Yamada, Y., Kozone, I., Izumikawa, M., Hashimoto, J., Takagi, M., Omura, S., Shin-ya, K., et al. (2013) · ACS Synthetic Biology · doi:10.1021/sb3001003 · Cited by 223
Myronovskyi, M., Rosenkränzer, B., Nadmid, S., Pujic, P., Normand, P., & Luzhetskyy, A. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.09.004 · Cited by 222 · cited 1×
“To improve S. albus properties as a surrogate host, a cluster free strain was developed (Myronovskyi et al., 2018).”
Olano, C., García, I., González, A., Rodriguez, M., Rozas, D., Rubio, J., Sánchez‐Hidalgo, M., Braña, A. F., Méndez, C., & Salas, J. A. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12116 · Cited by 220 · cited 1×
“albus J1074, that had been previously identified using genome-mining approaches, with different approaches: insertion of a strong constitutive promoter (ermE*p), overexpression of the positive regulatory gene sshg_05706, and heterologous expression of the LuxR-family activator pimM of the pimaricin cluster (Olano et a…”
BackgroundMetabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes
Weber, T., Charusanti, P., Musiol-Kroll, E. M., Jiang, X., Tong, Y., Kim, H. U., & Lee, S. Y. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.10.009 · Cited by 219 · cited 2×
“Only in recent years have these technologies been applied to the optimization of NP biosynthesis in actinomycetes (Robertsen et al., 2018; Weber et al., 2015).”
MethodSelf-citationEngineering Broader Specificity into an Antibiotic-Producing Polyketide Synthase
Marsden, A. F. A., Wilkinson, B., Cortés, J., Dunster, N. J., Staunton, J., & Leadlay, P. F. (1998) · Science · doi:10.1126/science.279.5348.199 · Cited by 218
De novo design and engineering of non-ribosomal peptide synthetases
Bozhüyük, K. A. J., Fleischhacker, F., Linck, A., Wesche, F., Tietze, A., Niesert, C.-P., & Bode, H. B. (2018) · Nature Chemistry · doi:10.1038/nchem.2890 · Cited by 218
Hwang, K.-S., Kim, H. U., Charusanti, P., Palsson, B. Ø., & Lee, S. Y. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.008 · Cited by 218 · cited 1×
“Natural products (NP) are bioactive molecules that are used for many different purposes such as herbicides, chemotherapeutics, immunosuppressants, and antibiotics (Berdy, 2005; Berdy, 2012; Hwang et al., 2014).”
BackgroundSelf-citationThe structural biology of biosynthetic megaenzymes
Weissman, K. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1883 · Cited by 217 · cited 1×
“…whole genome sequencing, and the progress in understanding the structural blueprint of these megaenzymes and the interplay of the individual enzymatic domains (Keatinge-Clay, 2012; Kopp and Marahiel, 2007; Marahiel, 2016; Weissman, 2015) likely will provide novel approaches in the near future.”
BackgroundApplications and advances of metabolite biosensors for metabolic engineering
Liu, D., Evans, T., & Zhang, F. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.06.008 · Cited by 213 · cited 2×
“avermitilis wild-type and industrial strains led to a 22% increase of avermectin production (Liu et al., 2015).”
BackgroundMethodSiegl, T., Tokovenko, B., Myronovskyi, M., & Luzhetskyy, A. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.07.006 · Cited by 212 · cited 1×
“Saccharothrix espanaensis DSM 44229, and Salinispora tropica CNB- 440 (Siegl et al., 2013).”
BackgroundThiostrepton-induced gene expression in Streptomyces lividans
Murakami, T., Holt, T. G., & Thompson, C. J. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.3.1459-1466.1989 · Cited by 205 · cited 2×
“Inducible promoters often used are: the thiostrepton-inducible promoter PtipA (Murakami et al., 1989), requiring the TipAL protein; the synthetic tetracycline-inducible promoter tcp830 (Rodriguez-Garcia et al., 2005); and synthetic resorcinolinducible and cumate-inducible promoters (Horbal et al., 2014).”
BackgroundBai, C., Zhang, Y., Zhao, X., Hu, Y., Xiang, S., Miao, J., Lou, C., & Zhang, L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511027112 · Cited by 201
Blin, K., Kim, H. U., Medema, M. H., & Weber, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx146 · Cited by 200 · cited 3×
“…whole genome sequences can now be easily and cheaply obtained, genome mining for secondary metabolite biosynthetic gene clusters (BGCs) has become a routine method of NP discovery in actinomycetes (Ziemert et al., 2016) complementing the classical chemistry-driven screening (Blin et al., 2017).”
BackgroundMethodSelf-citationThe dynamic architecture of the metabolic switch in Streptomyces coelicolor
Nieselt, K., Battke, F., Herbig, A., Bruheim, P., Wentzel, A., Jakobsen, Ø. M., Sletta, H., Alam, M. T., Merlo, M. E., Moore, J., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-10 · Cited by 199
Macrocyclization strategies in polyketide and nonribosomal peptide biosynthesis
Kopp, F., & Marahiel, M. A. (2007) · Natural Product Reports · doi:10.1039/b613652b · Cited by 196
Jeong, Y., Kim, J.-N., Kim, M. W., Bucca, G., Cho, S., Yoon, Y. J., Kim, B.-G., Roe, J.-H., Kim, S. C., Smith, C. P., et al. (2016) · Nature Communications · doi:10.1038/ncomms11605 · Cited by 195 · cited 1×
“coelicolor A3(2) during different growth phases revealed that also translational control influences the expression of secondary metabolic genes in Streptomyces coelicolor A3(2) and that engineering the translational control systems could offer a novel strategy to enhance secondary metabolite production (Jeong et al.,…”
BackgroundMuyrers, J. P. P., Zhang, Y., Buchholz, F., & Stewart, A. F. (2000) · Genes & Development · doi:10.1101/gad.14.15.1971 · Cited by 194 · cited 1×
“The Red/ET system, consisting of coliphage I-derived protein pair, Redα/ Redβ, or the related RecET system using the RecE and RecT proteins from the Rac prophage can be used for in vivo homologous recombination (Muyrers et al., 2000; Sharan et al., 2009).”
MethodSystems metabolic engineering for chemicals and materials
Lee, J. W., Kim, T. Y., Jang, Y.-S., Choi, S., & Lee, S. Y. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.04.001 · Cited by 194
Self-citationA hybrid modular polyketide synthase obtained by domain swapping
Oliynyk, M., Brown, M. J. B., Cortés, J., Staunton, J., & Leadlay, P. F. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90069-1 · Cited by 184
Development of biosensors and their application in metabolic engineering
Zhang, J., Jensen, M. K., & Keasling, J. D. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.05.013 · Cited by 184
Bibb, M. J., White, J., Ward, J. M., & Janssen, G. R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb02187.x · Cited by 182 · cited 1×
“ermEp2, ermEp, and ermE*p (Bibb et al., 1985; Bibb et al., 1994; Schmitt-John and Engels, 1992; Takano et al., 1995); the phage I19 E.”
Molecular Basis for Chloronium-mediated Meroterpene Cyclization
Winter, J. M., Moffitt, M. C., Zazopoulos, E., McAlpine, J. B., Dorrestein, P. C., & Moore, B. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611046200 · Cited by 181
Engineered riboswitches: Expanding researchers' toolbox with synthetic RNA regulators
Wittmann, A., & Suess, B. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.038 · Cited by 172 · cited 1×
“permeable small molecules that are not metabolized by the cell (Topp and Gallivan, 2008; Wittmann and Suess, 2012).”
BackgroundCell-free synthetic biology: Engineering in an open world
Lu, Y. (2017) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2017.02.003 · Cited by 167 · cited 1×
“In order to overcome problems associated with the complexity of living organisms and the negative impacts of bioactive molecule overproduction to the host, an emerging technology for NP production is constituted by in vitro, cell-free platforms (Li et al., 2018; Lu, 2017).”
BackgroundGenetic engineering of modular PKSs: from combinatorial biosynthesis to synthetic biology
Weissman, K. J. (2015) · Natural Product Reports · doi:10.1039/c5np00109a · Cited by 166 · cited 1×
“An increased amount of polyketides or derivatives can be produced by expression of engineered PKSs in which one or more whole modules are replaced while maintaining protein integrity and interactions (Weissman, 2016).”
BackgroundA High-Throughput Screen for Synthetic Riboswitches Reveals Mechanistic Insights into Their Function
Lynch, S. A., Desai, S. K., Sajja, H. K., & Gallivan, J. P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.12.008 · Cited by 165 · cited 1×
“A very promising tool that does not rely on additional elements is use of regulatory RNA, specifically synthetic riboswitches (Lynch et al., 2007).”
BackgroundMetabolic engineering of microorganisms: general strategies and drug production
Lee, S. Y., Kim, H. U., Park, J. H., Park, J. M., & Kim, T. Y. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.08.004 · Cited by 165 · cited 1×
“their GC-rich genomes and morphological/physiological characteristics, specifically their filamentous morphology and slow growth (Lee et al., 2009).”
BackgroundSelf-citationYang, D., Kim, W. J., Yoo, S. M., Choi, J. H., Ha, S. H., Lee, M. H., & Lee, S. Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808567115 · Cited by 165
Self-citationTranslation initiation and the fate of bacterial mRNAs
Kaberdin, V. R., & Bläsi, U. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00043.x · Cited by 163 · cited 1×
“In addition to regulation on the transcriptional level, translation initiation and translation efficiency also strongly affect protein yield (Figure 2) (Kaberdin and Bläsi, 2006).”
BackgroundSystematic Identification of a Panel of Strong Constitutive Promoters from Streptomyces albus
Luo, Y., Zhang, L., Barton, K. W., & Zhao, H. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00016 · Cited by 162
Larionov, V, Kouprina, N., Graves, J., Chen, X. N., Korenberg, J. R., & Resnick, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.491 · Cited by 161 · cited 2×
“cerevisiae was described for the first time by Kouprina and Larionov (Kouprina et al., 1997; Larionov et al., 1996) for cloning selective genomic loci from human DNA.”
BackgroundMethodStreptomyces species: Ideal chassis for natural product discovery and overproduction
Liu, R., Deng, Z., & Liu, T. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.05.015 · Cited by 161
Feng, Z., Kallifidas, D., & Brady, S. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103921108 · Cited by 160 · cited 1×
“Today, this method is used in many laboratories for the direct cloning and DNA assembly of bacterial genes and BGCs (Feng et al., 2011; Kim et al., 2010).”
MethodPalazzotto, E., & Weber, T. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.03.004 · Cited by 159
Self-citationNative and engineered promoters in natural product discovery
Myronovskyi, M., & Luzhetskyy, A. N. (2016) · Natural Product Reports · doi:10.1039/c6np00002a · Cited by 156 · cited 1×
“available to finely control gene expression levels for streptomycetes (Myronovskyi and Luzhetskyy, 2016).”
BackgroundThe influence of carbon sources and morphology on nystatin production by Streptomyces noursei
Jonsbu, E., McIntyre, M., & Nielsen, J. (2002) · Journal of Biotechnology · doi:10.1016/s0168-1656(02)00003-2 · Cited by 153
Covington, B. C., McLean, J. A., & Bachmann, B. O. (2017) · Natural Product Reports · doi:10.1039/c6np00048g · Cited by 150 · cited 2×
“about differentially abundant molecules such as oasamycin and desertomycin (Covington et al., 2017; Doroghazi et al., 2014).”
BackgroundAntibiotic Overproduction in Streptomyces coelicolor A3(2) Mediated by Phosphofructokinase Deletion
Borodina, I., Siebring, J., Zhang, J., Smith, C. P., van Keulen, G., Dijkhuizen, L., & Nielsen, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803105200 · Cited by 146 · cited 1×
“Successful manipulation of the central carbohydrate metabolism has been reported for the increased production of several PKs such as erythromycin, oligomycin, monensin B, and actinorhodin (Borodina et al., 2008; Reeves et al., 2007; Ryu et al., 2006).”
BackgroundKim, J. H., Feng, Z., Bauer, J. D., Kallifidas, D., Calle, P. Y., & Brady, S. F. (2010) · Biopolymers · doi:10.1002/bip.21450 · Cited by 144
Gomez‐Escribano, J. P., & Bibb, M. J. (2013) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-013-1348-5 · Cited by 142
Ryu, Y.-G., Butler, M. J., Chater, K. F., & Lee, K. J. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.01308-06 · Cited by 141 · cited 2×
“Successful manipulation of the central carbohydrate metabolism has been reported for the increased production of several PKs such as erythromycin, oligomycin, monensin B, and actinorhodin (Borodina et al., 2008; Reeves et al., 2007; Ryu et al., 2006).”
BackgroundRuan, X., Pereda, A., Stassi, D. L., Zeidner, D., Summers, R. G., JACKSON, M., Shivakumar, A., Kakavas, S. J., Staver, M. J., Donadio, S., et al. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.20.6416-6425.1997 · Cited by 138
Breaking the silence: new strategies for discovering novel natural products
Ren, H., Wang, B., & Zhao, H. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.02.008 · Cited by 136 · cited 1×
“global regulator manipulation, ribosome engineering, and other rational modifications (Figure 2) (Nah et al., 2017; Ren et al., 2017).”
BackgroundLi, L., Zheng, G., Chen, J., Ge, M., Jiang, W., & Lü, Y. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.01.004 · Cited by 136 · cited 1×
“MSGE is a general metabolic engineering approach allowing a single step multi-copy chromosomal integration of a target BGC by the “one integrase-multiple attB sites” concept (Li et al., 2017).”
BackgroundCRISPR/Cas-based genome engineering in natural product discovery
Tong, Y., Weber, T., & Lee, S. Y. (2019) · Natural Product Reports · doi:10.1039/c8np00089a · Cited by 135 · cited 1×
“deletion, insertion, site direct mutagenesis in Streptomyces and also many genetically recalcitrant organisms (Huang et al., 2015; Kim et al., 2017; Tong et al., 2018).”
BackgroundSelf-citationCharacterization of the ‘pristinamycin supercluster’ of Streptomyces pristinaespiralis
Mast, Y., Weber, T., Gölz, M., Ort‐Winklbauer, R., Gondran, A., Wohlleben, W., & Schinko, E. (2010) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00213.x · Cited by 130 · cited 1×
“The compounds are synthesized by a NRPS and a hybrid PKS/NRPS assembly line, respectively (Mast et al., 2011; Mast et al., 2011).”
BackgroundSelf-citationA structural model for multimodular NRPS assembly lines
Marahiel, M. A. (2015) · Natural Product Reports · doi:10.1039/c5np00082c · Cited by 130 · cited 1×
“…whole genome sequencing, and the progress in understanding the structural blueprint of these megaenzymes and the interplay of the individual enzymatic domains (Keatinge-Clay, 2012; Kopp and Marahiel, 2007; Marahiel, 2016; Weissman, 2015) likely will provide novel approaches in the near future.”
BackgroundYuzawa, S., Deng, K., Wang, G., Baidoo, E. E. K., Northen, T. R., Adams, P. D., Katz, L., & Keasling, J. D. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00176 · Cited by 125
Morphogenesis of Streptomyces in Submerged Cultures
van Dissel, D., Claessen, D., & van Wezel, G. P. (2014) · Advances in applied microbiology · doi:10.1016/b978-0-12-800259-9.00001-9 · Cited by 123
Rodríguez-García, A., Combes, P., Pérez-Redondo, R., Smith, M. C. A., & Smith, M. C. M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni086 · Cited by 118 · cited 1×
“, 1989), requiring the TipAL protein; the synthetic tetracycline-inducible promoter tcp830 (Rodriguez-Garcia et al., 2005); and synthetic resorcinolinducible and cumate-inducible promoters (Horbal et al.”
BackgroundMetabolic Engineering of Microorganisms for the Production of Natural Compounds
Park, S. Y., Yang, D., Ha, S. H., & Lee, S. Y. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700190 · Cited by 117 · cited 1×
“, 2012; Lee and Kim, 2015) advancing rapidly will help establish even more efficient platforms for engineering actinomycetes for producing valuable natural and non-natural products (Kim et al., 2016; Park et al., 2018).”
BackgroundSelf-citationLin, J., Wagner, J. M., & Alper, H. S. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.07.005 · Cited by 115
Kang, H., Charlop–Powers, Z., & Brady, S. F. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00080 · Cited by 113 · cited 3×
“This method was applied to tetarimycin, lazarimide, and AB1210 gene clusters promoter refactoring (Kang et al., 2016).”
MethodInfluentialNah, H.-J., Pyeon, H.-R., Kang, S.-H., Choi, S.-S., & Kim, E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00394 · Cited by 113 · cited 1×
“global regulator manipulation, ribosome engineering, and other rational modifications (Figure 2) (Nah et al., 2017; Ren et al., 2017).”
BackgroundDirect Pathway Cloning (DiPaC) to unlock natural product biosynthetic potential
Greunke, C., Duell, E. R., D’Agostino, P. M., Glöckle, A., Lamm, K., & Gulder, T. A. M. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.03.010 · Cited by 110
Current state and applications of microbial genome-scale metabolic models
Kim, W. J., Kim, H. U., & Lee, S. Y. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.03.001 · Cited by 109
Self-citationThe Interrelationship between Promoter Strength, Gene Expression, and Growth Rate
Bienick, M. S., Young, K. W., Klesmith, J. R., Wrenbeck, E. E., Tomek, K. J., & Whitehead, T. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109105 · Cited by 109 · cited 1×
“titer of the desired product are commonly observed (Bienick et al., 2014; Pitera et al., 2007).”
BackgroundTan, G., Deng, K., Liu, X., Tao, H., Chang, Y., Chen, J., Chen, K., Sheng, Z., Deng, Z., & Liu, T. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00330 · Cited by 108 · cited 1×
“albus leading to a 1000× increased production compared to the original heterologous expression experiment (Tan et al., 2017).”
BackgroundApplications of genome-scale metabolic network model in metabolic engineering
Kim, B., Kim, W. J., Kim, D. I., & Lee, S. Y. (2015) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-014-1554-9 · Cited by 106 · cited 2×
“…contributed to the discovery and production of new NPs. Systems metabolic engineering strategies (Lee et al., 2011; Lee et al., 2012; Lee and Kim, 2015) advancing rapidly will help establish even more efficient platforms for engineering actinomycetes for producing valuable natural and…”
BackgroundSelf-citationXu, H., Chater, K. F., Deng, Z., & Tao, M. (2008) · Journal of Bacteriology · doi:10.1128/jb.01849-07 · Cited by 106
Nepal, K. K., & Wang, G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.10.003 · Cited by 105 · cited 1×
“Besides engineering the native host strains as described above, cloning the BGCs of interest and expressing them heterologously in a well-characterized host has emerged as an alternative strategy for BGC activation and new NP discovery (Nepal and Wang, 2018).”
BackgroundHashimoto, T., Hashimoto, J., Teruya, K., Hirano, T., Shin-ya, K., Ikeda, H., Liu, H.-W., Nishiyama, M., & Kuzuyama, T. (2015) · Journal of the American Chemical Society · doi:10.1021/ja510711x · Cited by 104 · cited 1×
“, 2009), and the versipelostatin BGC from Streptomyces versipellis (Hashimoto et al., 2015).”
BackgroundBrown, A. S., Calcott, M. J., Owen, J. G., & Ackerley, D. F. (2018) · Natural Product Reports · doi:10.1039/c8np00036k · Cited by 103
Engineered polyketides: Synergy between protein and host level engineering
Barajas, J. F., Blake-Hedges, J. M., Bailey, C. B., Curran, S., & Keasling, J. D. (2017) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2017.08.005 · Cited by 102
Heterologous Expression of Novobiocin and Clorobiocin Biosynthetic Gene Clusters
Eustáquio, A. S., Gust, B., Galm, U., Li, S.-M., Chater, K. F., & Heide, L. E. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.5.2452-2459.2005 · Cited by 96 · cited 1×
“…were used as the heterologous host to express and produce different classes of NPs as in the case of the BGCs encoding novobiocin and clorobiocin (Eustáquio et al., 2005), salinomycin (Yin et al., 2015), and R1 and roseophilin (Kimata et al., 2017), these last two being unique…”
MethodReeves, A. R., Brikun, I. A., Cernota, W. H., Leach, B. I., GONZALEZ, M., & MARKWEBER, J. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2007.02.001 · Cited by 96 · cited 1×
“Successful manipulation of the central carbohydrate metabolism has been reported for the increased production of several PKs such as erythromycin, oligomycin, monensin B, and actinorhodin (Borodina et al., 2008; Reeves et al., 2007; Ryu et al., 2006).”
BackgroundGuo, F., Xiang, S., Li, L., Wang, B., Rajasärkkä, J., Gröndahl‐Yli‐Hannuksela, K., Ai, G., Metsä‐Ketelä, M., & Yang, K. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2014.12.006 · Cited by 96
Evolution-guided engineering of nonribosomal peptide synthetase adenylation domains
Crüsemann, M., Kohlhaas, C., & Piel, J. (2012) · Chemical Science · doi:10.1039/c2sc21722h · Cited by 92
Horbal, L., Fedorenko, V., & Luzhetskyy, A. N. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5918-x · Cited by 92 · cited 3×
“These regulatory devices are based on cumate switches or resorcinol switches, which regulate the gene expression at the transcriptional level (Horbal et al., 2014), the theophylline riboswitch (Rudolph et al.”
BackgroundInfluentialEngineering polyketide synthases and nonribosomal peptide synthetases
Williams, G. J. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.06.012 · Cited by 91 · cited 2×
“Recently, Abe and co-workers demonstrated that the strategy proposed by Bode and co-workers (Bozhüyük et al., 2018) to manipulate NRPSs and the general strategies to engineer PKSs can be also applied to hybrid NRPS-PKS engineering (Williams, 2013).”
BackgroundSynthetic riboswitches for the conditional control of gene expression in Streptomyces coelicolor
Rudolph, M. M., Vockenhuber, M.-P., & Suess, B. (2013) · Microbiology · doi:10.1099/mic.0.067322-0 · Cited by 90 · cited 2×
“, 2014), the theophylline riboswitch (Rudolph et al., 2013), or the hammerhead ribozyme that instead controls translation initiation (Horbal et al.”
BackgroundMo, S., Ban, Y. H., Park, J. W., Yoo, Y. J., & Yoon, Y. J. (2009) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-009-0635-7 · Cited by 88 · cited 1×
“mily of NPs built from acyl-CoA monomers (Chan et al., 2009; Mo et al., 2009).”
BackgroundLi, L., Zhao, Y., Ruan, L., Yang, S., Ge, M., Jiang, W., & Lü, Y. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.02.001 · Cited by 87 · cited 1×
“pristinaespiralis growth (Li et al., 2015), a strain producing high titer of only pristinamycin I, was generated by Lu and co-worker by deletion of papR3 repressor gene and the integration of an extra copy of PI BGC”
MethodEngineering the Substrate Specificity of the DhbE Adenylation Domain by Yeast Cell Surface Display
Zhang, K., Nelson, K. M., Bhuripanyo, K., Grimes, K. D., Zhao, B., Aldrich, C. C., & Yin, J. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.10.020 · Cited by 87
Phage P1-Derived Artificial Chromosomes Facilitate Heterologous Expression of the FK506 Gene Cluster
Jones, A. C., Gust, B., Kulik, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069319 · Cited by 85 · cited 1×
“In 2013, the Bibb group used a PAC library to clone and express the entire 83.5 kb FK506 (tacrolimus) gene cluster from S. tsukubaensis NRRL 18488 in four different S. coelicolor A3(2) hosts (Jones et al., 2013).”
MethodInfluentialHuang, D., Li, S., Xia, M., Wen, J., & Jia, X. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-52 · Cited by 85 · cited 1×
“The yield of FK506 in Streptomyces tsukubaensis was increased by 161% (Huang et al., 2013; Wang et al., 2017).”
BackgroundAhn, S. K., Cuthbertson, L., & Nodwell, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050562 · Cited by 82
Random Walks to Synthetic Riboswitches—A High‐Throughput Selection Based on Cell Motility
Topp, S., & Gallivan, J. P. (2007) · ChemBioChem · doi:10.1002/cbic.200700546 · Cited by 82 · cited 1×
“permeable small molecules that are not metabolized by the cell (Topp and Gallivan, 2008; Wittmann and Suess, 2012).”
BackgroundZabala, D., Braña, A. F., Flórez, A. B., Salas, J. A., & Méndez, C. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.10.002 · Cited by 81 · cited 1×
“argillaceus, or by inactivation of the acyl-CoA:diacylglycerol acyltransferase gene aftAa (Zabala et al., 2013).”
BackgroundThe secreted metabolome of Streptomyces chartreusis and implications for bacterial chemistry
Senges, C. H. R., Al-Dilaimi, A., Marchbank, D. H., Wibberg, D., Winkler, A., Haltli, B., Nowrousian, M., Kalinowski, J., Kerr, R. G., & Bandow, J. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715713115 · Cited by 81 · cited 1×
“producer strain of calcimycin and tunicamycin (Doroghazi et al., 2011; Senges et al., 2018), was cultivated in different media and analyzed by”
BackgroundCloning and Heterologous Expression of the Grecocycline Biosynthetic Gene Cluster
Bilyk, O., Sekurova, O. N., Zotchev, S. B., & Luzhetskyy, A. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158682 · Cited by 80 · cited 1×
“Acta 1362 (Bilyk et al., 2016); and the aromatic PK antitumor agent cosmomycin (Larson et al.”
BackgroundHorinouchi, S., & Beppu, T. (1992) · Gene · doi:10.1016/0378-1119(92)90555-4 · Cited by 78 · cited 1×
“The best-studied GBL is the so-called A-factor (2- isocapryloyl-3R-hydroxymethyl-gamma-butyrolactone) of Streptomyces griseus (Horinouchi and Beppu, 1992).”
BackgroundTao, W., Yang, A., Deng, Z., & Sun, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01660 · Cited by 73 · cited 1×
“vector construction in recent years, cloning large-sized DNA harboring entire BGCs with repetitive sequences remains a challenging task (Tao et al., 2018).”
BackgroundWard, S. L., Hu, Z., Schirmer, A., Reid, R., Revill, W. P., Reeves, C. D., Petrakovsky, O. V., Dong, S. D., & Katz, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4703-4712.2004 · Cited by 72
Secondary metabolites overproduction through transcriptional gene cluster refactoring
Horbal, L., Marques, F., Nadmid, S., Mendes, M. V., & Luzhetskyy, A. N. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.09.010 · Cited by 71 · cited 3×
“, 2000); and recently the ttsbiB terminator from Mycobacteria, which was reported to also be effective in Streptomyces (Horbal et al., 2018).”
BackgroundMethodInfluentialYang, P., Wang, J., Pang, Q., Zhang, F., Wang, J., Wang, Q., & Qi, Q. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.08.001 · Cited by 70
Alexander, D. C., Rock, J. L., He, X., Brian, P., Miao, V., & Baltz, R. H. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01248-10 · Cited by 70
Ji, C.-H., Kim, J.-P., & Kang, H. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00175 · Cited by 69 · cited 1×
“To overcome the unexpected formation of secondary structures that can possibly cause the cross-recombination between very similar regulatory sequences inserted into a single gene cluster, a library of constitutively active, synthetic Streptomyces regulatory sequences with the highest sequence divergence was generated…”
BackgroundJordan, P. A., & Moore, B. S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.10.009 · Cited by 69
SHAH, S., XUE, Q., TANG, L., Carney, J. R., Betlach, M. C., & McDaniel, R. N. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.502 · Cited by 68
In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing
Liu, Y., Tao, W., Wen, S., Li, Z., Yang, A., Deng, Z., & Sun, Y. (2015) · mBio · doi:10.1128/mbio.01714-15 · Cited by 68
Kim, H. U., Charusanti, P., Lee, S. Y., & Weber, T. (2016) · Natural Product Reports · doi:10.1039/c6np00019c · Cited by 67 · cited 1×
“, 2012; Lee and Kim, 2015) advancing rapidly will help establish even more efficient platforms for engineering actinomycetes for producing valuable natural and non-natural products (Kim et al., 2016; Park et al., 2018).”
BackgroundSelf-citationReprogramming of the antimycin NRPS-PKS assembly lines inspired by gene evolution
Awakawa, T., Fujioka, T., Zhang, L., Hoshino, S., Hu, Z., Hashimoto, J., Kozone, I., Ikeda, H., Shin‐ya, K., Liu, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05877-z · Cited by 67
Understanding and manipulating antibiotic production in actinomycetes
Bibb, M. J. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130214 · Cited by 67
Cell-free synthetic biology for in vitro biosynthesis of pharmaceutical natural products
Li, J., Zhang, L., & Liu, W. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.02.002 · Cited by 67
Fang, A., Pierson, D. L., Mishra, S. K., & Demain, A. L. (2000) · Applied Microbiology and Biotechnology · doi:10.1007/s002539900303 · Cited by 65 · cited 1×
“In these strains, the high production of rapamycin and nystatin was associated with the formation of dispersed mycelium or dense pellets, respectively (Fang et al., 2000; Jonsbu et al., 2002).”
BackgroundZhou, M., Jing, X., Xie, P., Chen, W., Wang, T., Xia, H., & Qin, Z. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02609.x · Cited by 65
Horbal, L., Siegl, T., & Luzhetskyy, A. N. (2018) · Scientific Reports · doi:10.1038/s41598-017-18846-1 · Cited by 64
ClusterCAD: a computational platform for type I modular polyketide synthase design
Eng, C. H., Backman, T. W. H., Bailey, C. B., Magnan, C., Martín, H. G., Katz, L., Baldi, P., & Keasling, J. D. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx893 · Cited by 62
Liu, H., Jiang, H., Haltli, B., Kulowski, K., Muszynska, E., Feng, X., Summers, M. Y., Young, M., Graziani, E. I., Koehn, F. E., et al. (2009) · Journal of Natural Products · doi:10.1021/np8006149 · Cited by 62
Tan, G., Peng, Y., Lu, C., Bai, L., & Zhong, J. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2014.12.003 · Cited by 62 · cited 1×
“hygroscopicus was increased by 55% (Tan et al., 2015).”
Auroramycin: A Potent Antibiotic from Streptomyces roseosporus by CRISPR‐Cas9 Activation
Lim, Y. H., Wong, F. T., Yeo, W. L., Ching, K. C., Lim, Y. W., Heng, E., Chen, S., Tsai, D., Lauderdale, T.-L. Y., Shia, K., et al. (2018) · ChemBioChem · doi:10.1002/cbic.201800266 · Cited by 62 · cited 2×
“promoter to constitutively express the transcriptional activator of the auroramycin BGC (Lim et al., 2018).”
BackgroundMethodLiu, J., Chen, Y., Wang, W., Ren, M., Wu, P., Wang, Y., Li, C., Zhang, L., Wu, H., Weaver, D. T., et al. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.10.012 · Cited by 62 · cited 1×
“This operon codes for a branched-chain amino acid ABC transporter (Liu et al., 2017).”
BackgroundCRISPR-mediated isolation of specific megabase segments of genomic DNA
Bennett‐Baker, P. E., & Mueller, J. L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx749 · Cited by 61
Liu, W., Zhang, Q., Guo, J., Chen, Z., Li, J., & Wen, Y. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00868-15 · Cited by 61 · cited 4×
“In 2015, a highly efficient in vitro CRISPR/Cas9-mediated editing (ICE) system was developed exploiting CRISPR/Cas9 as an in vitro programmable endonuclease to edit actinomycete BGCs while avoiding non-specific recombination (Liu et al., 2015).”
BackgroundMethodInfluentialPolyketide Bioderivatization Using the Promiscuous Acyltransferase KirCII
Musiol-Kroll, E. M., Zubeil, F., Schafhauser, T., Härtner, T., Kulik, A., McArthur, J. B., Koryakina, I., Wohlleben, W., Grond, S., Williams, G. J., et al. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00341 · Cited by 53
Self-citationDunn, B. J., Watts, K. R., Robbins, T., Cane, D. E., & Khosla, C. (2014) · Biochemistry · doi:10.1021/bi5004316 · Cited by 53
Yin, J., Hoffmann, M., Bian, X., Tu, Q., Yan, F., Xia, L., Ding, X., Stewart, A. F., Müller, R., Fu, J., et al. (2015) · Scientific Reports · doi:10.1038/srep15081 · Cited by 52
Huang, D., Li, Z.-H., You, D., Zhou, Y. Q., & Ye, B. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6144-2 · Cited by 49 · cited 2×
“the acetylproteome of Saccharopolyspora erythraea, the producer of erythromycin (Huang et al., 2015).”
BackgroundAcyltransferases as Tools for Polyketide Synthase Engineering
Musiol-Kroll, E. M., & Wohlleben, W. (2018) · Antibiotics · doi:10.3390/antibiotics7030062 · Cited by 49
Castro, J. F., Razmilic, V., Gomez‐Escribano, J. P., Andrews, B. A., Asenjo, J. A., & Bibb, M. J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.01039-15 · Cited by 46
Yi, J. S., Kim, M. W., Kim, M., Jeong, Y., Kim, E.-J., Cho, B., & Kim, B. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00263 · Cited by 46 · cited 1×
“For designing an efficient gene expression system, relying only on the measurement of mRNA transcript levels is not enough (Yi et al., 2017).”
MethodNah, H.-J., Woo, M.-W., Choi, S.-S., & Kim, E. S. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0325-2 · Cited by 45 · cited 1×
“logously overexpress the tautomycetin BGC (Nah et al., 2015).”
Sohoni, S. V., Fazio, A., Workman, C. T., Mijakovic̀, I., & Lantz, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099701 · Cited by 45
Licona‐Cassani, C., Marcellin, E., Quek, L., Jacob, S. S., & Nielsen, L. K. (2012) · Antonie van Leeuwenhoek · doi:10.1007/s10482-012-9783-2 · Cited by 41 · cited 1×
“the potential benefit of amino acid supplementation to erythromycin production (Licona-Cassani et al., 2012).”
BackgroundCoze, F., Gilard, F., Tcherkez, G. G. B., Virolle, M., & Guyonvarch, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084151 · Cited by 41
Doroghazi, J. R., Ju, K., Brown, D. W., Labeda, D. P., Deng, Z., Metcalf, W. W., Chen, W., & Price, N. P. J. (2011) · Journal of Bacteriology · doi:10.1128/jb.06262-11 · Cited by 40 · cited 1×
“producer strain of calcimycin and tunicamycin (Doroghazi et al., 2011; Senges et al., 2018), was cultivated in different media and analyzed by”
BackgroundIzumikawa, M., Kozone, I., Hashimoto, J., Kagaya, N., Takagi, M., Koiwai, H., Komatsu, M., Fujie, M., Satoh, N., Ikeda, H., et al. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.20 · Cited by 40
Development of Streptomyces sp. FR-008 as an emerging chassis
Liu, Q., Xiao, L., Zhou, Y., Deng, K., Tan, G., Han, Y., Liu, X., Deng, Z., & Liu, T. (2016) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2016.07.002 · Cited by 40 · cited 3×
“The results obtained in this work provided useful biological elements for genetic engineering and expression of exogenous genes in FR-008.”
BackgroundInfluentialGao, W., Wu, Z., Sun, J., Ni, X., & Xia, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181971 · Cited by 40 · cited 1×
“In order to obtain an optimal kanamycin A-producing strain, the kanJ and kanK genes, which encode two enzymes responsible for converting kanamycin B to kanamycin A, were overexpressed (Gao et al., 2017).”
BackgroundTryptophan promotes morphological and physiological differentiation in Streptomyces coelicolor
Palazzotto, E., Renzone, G., Fontana, P., Botta, L., Scaloni, A., Puglia, A. M., & Gallo, G. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7012-4 · Cited by 39 · cited 2×
“coelicolor A3(2), the production of the type II PK actinorhodin was induced by increased levels of the precursor acetyl-CoA, derived from glucose, and amino acid degradation pathways (Palazzotto et al., 2015; Stirrett et al., 2009).”
BackgroundSelf-citationBotas, A., Pèrez‐Redondo, R., Rodríguez‐García, A., Álvarez-Álvarez, R., Yagüe, P., Manteca, Á., & Liras, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00361 · Cited by 35 · cited 1×
“particular, a transcriptomics based approach has been used to investigate the complex network of signaling and regulatory proteins controlling the morpho-physiological differentiation occurring during actinomycetes growth (Botas et al., 2018; Zhou et al., 2015).”
MethodToro, L. F., Pinilla, L., Avignone-Rossa, C. A., & Ríos‐Estepa, R. (2018) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-018-1900-9 · Cited by 33
Hu, W., Zhao, G., & Ding, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-13493-y · Cited by 33
Horbal, L., & Luzhetskyy, A. N. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.03.008 · Cited by 33 · cited 1×
“Due to the need of a non-leaky inducible system controlling the gene expression at both transcriptional and translational level, Horbal and Luzhetskyy developed a series of dual control regulatory devices in Actinobacteria, completely silent in the absence of inputs and, at the same time, highly inducible (Horbal and…”
BackgroundGenome‐Scale Metabolic Reconstruction of Actinomycetes for Antibiotics Production
Mohite, O. S., Weber, T., Kim, H. U., & Lee, S. Y. (2018) · Biotechnology Journal · doi:10.1002/biot.201800377 · Cited by 32 · cited 1×
“To date, twelve actinomycetes GEMs were reconstructed (Mohite et al., 2018)”
BackgroundSelf-citationDang, L., Liu, J., Wang, C., Liu, H., & Wen, J. (2017) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-016-1880-1 · Cited by 31
Wang, X., Zhang, C., Wang, M., & Lu, W. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-41 · Cited by 30
Park, O., Choi, H., Kim, G., & Kim, W. (2016) · ChemBioChem · doi:10.1002/cbic.201600241 · Cited by 29
Wu, H., Chen, M., Mao, Y., Li, W., Liu, J., Huang, X., Zhou, Y. Q., Ye, B., Zhang, L., Weaver, D. T., et al. (2014) · Microbial Cell Factories · doi:10.1186/s12934-014-0158-4 · Cited by 29
Conditional Control of Gene Expression by Synthetic Riboswitches in Streptomyces coelicolor
Rudolph, M. M., Vockenhuber, M.-P., & Suess, B. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.10.036 · Cited by 28 · cited 1×
“By cloning different synthetic theophylline-responsive riboswitches in front of a ß- glucuronidase reporter gene (gusA) and an endogenous agarase gene, the authors showed a dose-dependent activation of both reporter genes and the orthogonality of riboswitch regulation (Rudolph et al., 2013; Rudolph et al., 2015).”
BackgroundSystems metabolic engineering in an industrial setting
Sagt, C. M. J. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4738-8 · Cited by 27 · cited 1×
“In recent years, various metabolic engineering strategies have been developed and integrated with other fields, such as systems biology and synthetic biology, to discover new BGCs and create industrial producer strains (Sagt, 2013).”
BackgroundWang, C., Liu, J., Liu, H., Liang, S., & Wen, J. (2017) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-017-1974-4 · Cited by 27 · cited 2×
“baensis, in which the production of tacrolimus was optimized by evaluating the intracellular response to enhancement of malonate, lysine, shikimate, and citrate synthetic precursor pathways in tacrolimus biosynthesis (Wang et al., 2017).”
BackgroundMethodYuzawa, S., Kapur, S., Cane, D. E., & Khosla, C. (2012) · Biochemistry · doi:10.1021/bi300399u · Cited by 27
Chen, W., & Qin, Z. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-243 · Cited by 26
Larson, C. B., Crüsemann, M., & Moore, B. S. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b01121 · Cited by 26 · cited 1×
“, 2016); and the aromatic PK antitumor agent cosmomycin (Larson et al., 2017).”
BackgroundGenome‐scale metabolic representation of Amycolatopsis balhimycina
Vongsangnak, W., de Figueiredo, L. F., Förster, J., Weber, T., Thykær, J., Stegmann, E., Wohlleben, W., & Nielsen, J. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24436 · Cited by 24
Self-citationFondi, M., Pinatel, E., Talà, A., Damiano, F., Consolandi, C., Mattorre, B., Fico, D., Testini, M., Benedetto, G. E. D., Siculella, L., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00835 · Cited by 18 · cited 1×
“…system biology approach, using constraintbased metabolic modeling with time-resolved RNA-seq data, was adopted to characterize the Streptomyces ambofaciensmetabolism and to identify potential metabolic engineering targets for the overproduction of the secondary metabolites (Fondi et al., 2017).”
MethodRui, Z., Huang, W. S., Xu, F., Han, M., Liu, X., Lin, S., & Zhang, W. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00284 · Cited by 17
Ishizuka, M., Imai, Y., Mukai, K., Shimono, K., Hamauzu, R., Ochi, K., & Hosaka, T. (2018) · Antonie van Leeuwenhoek · doi:10.1007/s10482-018-1021-0 · Cited by 17
Large inserts for big data: artificial chromosomes in the genomic era
Tocchetti, A., Donadio, S., & Sosio, M. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny064 · Cited by 13 · cited 1×
“Nevertheless, several methods have been established both in in vivo and in vitro to clone and assemble large DNA fragments harboring BGCs (Tocchetti et al., 2018).”
Zhou, Z., Xu, Q., Bu, Q., Liu, S., Yu, P., & Li, Y. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6132-6 · Cited by 11 · cited 1×
“particular, a transcriptomics based approach has been used to investigate the complex network of signaling and regulatory proteins controlling the morpho-physiological differentiation occurring during actinomycetes growth (Botas et al., 2018; Zhou et al., 2015).”
Method
Metadata
- Authors
- Palazzotto, E., Tong, Y., Lee, S. Y., & Weber, T.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 37
- Issue
- 6
- Pages
- 107366
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2922422116
- Cited by
- 169
- References
- 187
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.